Send to

Choose Destination
See comment in PubMed Commons below
Rev Alerg Mex. 2017;64 Suppl 2:s5-s65.

[Colombian Guidelines of clinical practice for the use of immunoglobulins in the treatment of replacement and immunomodulation].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

Asociación Colombiana de Alergia, Asma e Inmunología, Medellín, Antioquia, Colombia.


in English, Spanish

Immunoglobulins are heterodimeric proteins composed of 2 heavy chains and 2 light chains. Human immunoglobulin G (IgG) is a plasma derivative and contains more than 95% of IgG. The composition of IgG subclasses is similar to that of normal human plasma. Immunoglobulin therapy was first introduced more than 50 years ago, and its use has been described in numerous diseases. In Colombia, the importance of this immunomodulatory resource prompted the need for clinical practice guidelines to be available for its use. For this reason, a multidisciplinary group of experts was brought together and distributed in working groups, by specialties, in order to develop an initial manuscript. Systematic literature searches were undertaken; identified evidences were evaluated and classified to support a preliminary draft that was discussed, analyzed and amended. Recommendations were issued on the use of intravenous immunoglobulin in pathologies that include primary and secondary immunodeficiencies, autoimmune diseas es, neurological disorders, infections, transplants and miscellaneous conditions; grades were assigned to each one of them according to the GRADE system. The final result translated into recommendations that are put forth with the purpose to inform, guide and support on optimal use of this immunomodulatory resource.


Clinical practice guidelines; Immunoglobulin; Immunomodulation

PubMed Commons home

PubMed Commons


    Supplemental Content

    Loading ...
    Support Center